Coronavirus disease 2019 |
COVID-19 |
Dendritic cells |
DCs |
Human leukocyte antigen |
HLA |
Severe acute respiratory syndrome |
SARS |
Middle East respiratory syndrome |
MERS |
Receptor-binding domain |
RBD |
Positive-sense/negative-sense single-stranded RNA |
+/-ssRNA |
Interferon |
IFN |
Angiotensin-converting enzyme 2 |
ACE2 |
Dipeptidyl peptidase 4 |
DPP4 |
Acute respiratory distress syndrome |
ARDS |
Pathogen-associated molecular patterns |
PAMPS |
Pattern recognition receptors |
PRRs |
Toll-like receptors |
TLRs |
Dendritic cell-specific ICAM-3-grabbing non-integrin |
DC-SIGN |
Natural killer cell |
NK Cell |
Myeloid differentiation primary response 88 |
MyD88 |
Nuclear factor-kappa B |
NF-κB |
Angiotensin II |
Ang II |
C-reactive protein |
CRP |
Tuberculosis |
TB |
Body mass index |
BMI |
Lopinavir |
LPV |
Ritonavir |
RTV |
Chlorpromazine |
CPZ |
Modified vaccinia virus Ankara |
MVA |
Vitamin A deficiency |
VAD |
COVID-19-associated mucormycosis |
CAM |